Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

PIP decision type

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

PIP compliance check

Date of opinion

Compliance procedure number

Medicine type

Related medicine

Therapeutic area

Last updated

First published

1 results

Sort by

List item

Opinion/decision on a Paediatric investigation plan (PIP): Tysabri, natalizumab

Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Neurology
PIP number: EMEA-001095-PIP02-12, Route(s) of administration: Intravenous use, Pharmaceutical form(s): Concentrate for solution for infusion
Decision date: 19/10/2012, Last updated: 27/11/2012, Compliance check: V, 16/12/2016